Highest development stage: Approved

Development active

Gram-negative activity

Mechanism of Action/Target pathogen: Complicated urinary tract infections including acute pyelonephritis; other potential indications: hospital- acquired bacterial pneumonia/ventilator- associated bacterial pneumonia, complicated intra-abdominal infections